What does this source bring?
The study compares RLRL with atropine 0,01% in a crossover design.
It does not examine the simultaneous use of both methods. The choroidal parameters publication from DOI 10.1007 /s40123- 025-01169-0 describes the initial phase of the same study; We don't double the attempt.
CLAIM-RLRL-COMPAREScope of testing and verification
- The role of the record
- Source of the claim
- Population
- Children with myopia, single-center study
- N
- Not applicable / not determined within the verified range
- Geography
- China
- Observation (months)
- Not applicable / not determined within the verified range
- Comparator
- Atropine 0,01%
- Result
- The study compares RLRL with atropine 0,01% in a crossover design.
- Safety
- This record does not allow estimation of the frequency of rare adverse events.
- Device/structure
- Not applicable / not determined within the verified range
- Publisher of the publication
- Association for Research in Vision and Ophthalmology (ARVO)
- Financing
- Not determined within the proven range; see the declaration in full text.
- Conflicts of interest
- Not determined within the proven range. The absence of confirmation does not mean the absence of conflict.
- DOI
- 10.1167/tvst.14.4.22
- PMID
- 40266603
- What was checked
- Bibliographic metadata and abstract in Europe PMC / PubMed
- Date of verification
- 2026-09-09
This is the editorial card of the publication. The description does not replace the full text, supplementary data or instructions for a specific device.